Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Jenner Technologies in-licenses MTP-PE from Ciba

May 10, 1996

Allovectin-7 clinical results announced at AACR

May 3, 1996

Somatix receives patent coverage for GVAX

May 3, 1996

Preclinical results for DC101 presented at AACR

April 26, 1996

GVAX cleared to enter phase III testing

April 26, 1996

Mitsubishi in-licenses anti-HER2, will begin clinical evaluation soon

April 26, 1996

Alnorin reported in phase I

April 19, 1996

BR96 produced successfully in milk from transgenic goats

April 12, 1996

Virulizin clinical trials resume in pancreatic cancer

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Australian researchers discover new compound to treat long COVID
BioWorld
Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....
Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes
BioWorld
Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...